D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $100B
1-Year Return 23.04%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Quarter Return
+17.58%
1 Year Return
+23.04%
3 Year Return
+72.12%
5 Year Return
+130.88%
10 Year Return
+299.18%
AUM
$83B
AUM Growth
+$8.55B
Cap. Flow
-$12.7B
Cap. Flow %
-15.3%
Top 10 Hldgs %
14.69%
Holding
3,048
New
425
Increased
950
Reduced
1,165
Closed
286

Sector Composition

1 Technology 19.42%
2 Consumer Discretionary 14.02%
3 Healthcare 12.06%
4 Communication Services 9.1%
5 Financials 8.97%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
GAIN icon
2176
Gladstone Investment Corp
GAIN
$543M
$492K ﹤0.01%
+48,733
New +$492K
ARNC
2177
DELISTED
Arconic Corporation
ARNC
$491K ﹤0.01%
+16,473
New +$491K
MTZ icon
2178
MasTec
MTZ
$15B
$490K ﹤0.01%
+7,184
New +$490K
OVID icon
2179
Ovid Therapeutics
OVID
$88.9M
$490K ﹤0.01%
+212,393
New +$490K
PTC icon
2180
PTC
PTC
$24.5B
$490K ﹤0.01%
4,099
-24,141
-85% -$2.89M
NBA.WS
2181
DELISTED
New Beginnings Acquisition Corp. Redeemable Warrants, each warrant exercisable for one share of Comm
NBA.WS
$490K ﹤0.01%
+490,000
New +$490K
ONTO icon
2182
Onto Innovation
ONTO
$5.2B
$488K ﹤0.01%
10,262
-4,105
-29% -$195K
PGTI
2183
DELISTED
PGT, Inc.
PGTI
$485K ﹤0.01%
23,822
-9,639
-29% -$196K
RLGT icon
2184
Radiant Logistics
RLGT
$301M
$484K ﹤0.01%
83,439
+54,212
+185% +$314K
LFCR icon
2185
Lifecore Biomedical
LFCR
$262M
$480K ﹤0.01%
44,283
+28,432
+179% +$308K
STEP icon
2186
StepStone Group
STEP
$4.81B
$476K ﹤0.01%
+11,967
New +$476K
MRAM icon
2187
Everspin Technologies
MRAM
$154M
$474K ﹤0.01%
103,137
+19,311
+23% +$88.8K
PHI icon
2188
PLDT
PHI
$4.19B
$474K ﹤0.01%
+16,993
New +$474K
CMRE icon
2189
Costamare
CMRE
$1.46B
$473K ﹤0.01%
57,142
+32,463
+132% +$269K
TMP icon
2190
Tompkins Financial
TMP
$998M
$471K ﹤0.01%
+6,668
New +$471K
NBHC icon
2191
National Bank Holdings
NBHC
$1.47B
$469K ﹤0.01%
+14,330
New +$469K
EVFM
2192
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$469K ﹤0.01%
+12,967
New +$469K
EPAM icon
2193
EPAM Systems
EPAM
$8.53B
$466K ﹤0.01%
+1,301
New +$466K
GBIO icon
2194
Generation Bio
GBIO
$40.3M
$464K ﹤0.01%
+1,635
New +$464K
NC icon
2195
NACCO Industries
NC
$293M
$462K ﹤0.01%
17,569
-1,012
-5% -$26.6K
BMY.RT
2196
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$461K ﹤0.01%
667,318
-8,400
-1% -$5.8K
TA
2197
DELISTED
TravelCenters of America LLC
TA
$460K ﹤0.01%
+14,125
New +$460K
HSKA
2198
DELISTED
Heska Corp
HSKA
$460K ﹤0.01%
3,157
+128
+4% +$18.7K
SURF
2199
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$459K ﹤0.01%
+49,679
New +$459K
QTTB icon
2200
Q32 Bio
QTTB
$21.7M
$456K ﹤0.01%
+2,243
New +$456K